Action VELO VELOXIS PHARMACEUTICALS A/S
Ajouter à une liste
Pour utiliser cette fonction vous devez être client ou membre
ConnexionInscription

Autres langues Veloxis Pharmaceuticals A/S

Actions

VELO

DK0060048148

Temps Différé Nasdaq Copenhagen
Autres places de cotation
 		Varia. 5j. Varia. 1 janv.
- DKK -.--% Graphique intraday de Veloxis Pharmaceuticals A/S -.--% -0,50 %
2022 Veloxis Pharmaceuticals annonce le dosage du premier patient par son partenaire Xenikos dans l'étude mondiale de phase 3 évaluant T-Guard(R) chez les patients atteints de la maladie aiguë du greffon contre l'hôte réfractaire aux stéroïdes (SR-aGVHD) CI
2019 Transcript : Asahi Kasei Pharma Denmark A/S, Veloxis Pharmaceuticals A/S - M&A Call

Autres langues

Recherche
Voir les résultats
Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !
Inscription 100% Gratuite
Veloxis Pharmaceuticals Announces Dosing of the First Patient by partner Xenikos in the Global Phase 3 Study Evaluating T-Guard(R) in Patients with Steroid-Refractory Acute Graft-Versus-Host Disease (SR-aGVHD)
Scandion Oncology A/S : appoints Johnny Stilou as new CFO
Veloxis Pharmaceuticals, Inc entered into a global license agreement to acquire Worldwide Rights to FR104 from OSE Immunotherapeutics SA.
Veloxis Pharmaceuticals A/S : Extraordinary General Meeting of Veloxis Pharmaceuticals A/S, 17 February 2020
Veloxis Pharmaceuticals A/S Announces Board Appointments
Veloxis Pharmaceuticals A/S(CPSE:VELO) dropped from OMX Nordic All-Share Index
Veloxis Pharmaceuticals A/S(CPSE:VELO) dropped from S&P Global BMI Index
Veloxis Pharmaceuticals A/S(CPSE:VELO) dropped from S&P Global BMI Index
Veloxis Pharmaceuticals A/S : Nasdaq Copenhagen A/S has Accepted Veloxis Pharmaceuticals A/S' Request for Delisting of its Shares from Nasdaq Copenhagen A/S
Veloxis Pharmaceuticals A/S : - Notice to Convene Extraordinary General Meeting
Veloxis Pharmaceuticals A/S : Notice on Compulsory Acquisition to the Shareholders of Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals A/S : - Major Shareholder Notifications
Veloxis Pharmaceuticals A/S : Notice to Convene Extraordinary General Meeting
Veloxis Pharmaceuticals A/S : Announcement of Request for Delisting of Veloxis Pharmaceuticals A/S' Shares from Nasdaq Copenhagen
Veloxis Pharmaceuticals A/S : Notice on Compulsory Acquisition to the Shareholders of Veloxis Pharmaceuticals A/S
Veloxis Pharmaceuticals A/S: Major Shareholder Notifications
Veloxis Pharmaceuticals A/S : Increases Share Capital in Connection with Asahi Kasei Pharma Denmark's Exercise of Warrants Acquired under the Public Tender Offer
Veloxis Pharmaceuticals A/S : Asahi Kasei Pharma Denmark A/S Announces the Final Result of the Voluntary Public Tender Offer
Veloxis Pharmaceuticals A/S : Asahi Kasei Pharma Denmark A/S Announces the Final Result of the Voluntary Public Tender Offer
Veloxis Pharmaceuticals A/S : - Reporting of Managers and Closely Associated Persons Transactions in Veloxis-Shares and Financial Instruments Linked Hereto
Aucun résultat pour cette recherche
Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Filtres

Rechercher

Date de publication

Depuis le

Jusqu'au

  1. Bourse
  2. Actions
  3. Action VELO
  4. Actualités Veloxis Pharmaceuticals A/S
  5. Autres langues